De Wolf, Katrien
Kruse, Vibeke
Sundahl, Nora
van Gele, Mireille
Chevolet, Ines
Speeckaert, Reinhart
Brochez, Lieve
Ost, Piet
Clinical trials referenced in this document:
Documents that mention this clinical trial
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response
https://doi.org/10.1186/s12967-017-1123-x
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
https://doi.org/10.1136/jitc-2020-001429
Funding for this research was provided by:
Kom op Tegen Kanker
Article History
Received: 6 December 2016
Accepted: 19 January 2017
First Online: 31 January 2017